Submit Deal
All corporates
Similar corporates
Summary
Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.
Deals Overview
Market Context
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
Eric Murphy
co-founder and CEO
Scott Moorefield
COO/CBO
Deals (1)
Service Providers
Relationships
Portfolio
Team
Sort
Target: ALTEROME THERAPEUTICS
Bidder: GOLDMAN SACHS ASSET MANAGEMENT
5 Service Providers
6 Dealmakers
£ 105 M
Value
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy